July 4, 2022

Volume XII, Number 185

Advertisement
Advertisement

July 01, 2022

Subscribe to Latest Legal News and Analysis
Advertisement

HRSA Uninsured Program Shutdown: Funding to End March 22, 2022 for COVID-19 Testing and Treatment; April 5, 2022 for COVID-19 Vaccination

On March 15, 2022, the Health Resources & Services Administration (HRSA) announced that the Uninsured Program will stop accepting claims for COVID-19 testing and treatment on March 22, 2022 at 11:59 PM ET due to lack of sufficient funds. HRSA will stop accepting claims for COVID-19 vaccination on April 5, 2022 at 11:59 PM.

The HRSA Uninsured Program was funded by COVID-19 related legislation (including the Families First Coronavirus Response Act (FFCRA); the Coronavirus Aid, Relief and Economic Security Act; the Coronavirus Response and Relief Supplemental Appropriations Act; and the American Rescue Plan of 2021) and provides reimbursement for health care providers who render COVID-19 testing, treatment and vaccine services to uninsured individuals.

In a Frequently Asked Questions (FAQ) document (titled HRSA COVID-19 Uninsured Program Shutdown FAQs), HRSA stated that any claims for testing and treatment submitted to the claims portal after March 22, 2022, and after April 5, 2022 for COVID-19 vaccination, will not be adjudicated for payment. All claims submitted prior to the deadline will be adjudicated and paid subject to their eligibility and availability of funds.

HRSA lists several resources for uninsured individuals who need COVID-19 services, including enrollment with Medicaid or the Healthcare marketplace, COVIDtests.gov, and HRSA’s “Find a Health Center” resource. Importantly, the FAQ document states that pursuant to the Centers for Disease Control and Prevention’s COVID-19 Vaccination Program requirements, participating providers must continue to administer COVID-19 vaccines at no out-of-pocket costs to recipients.

HRSA has paid approximately $18,784,822,233 in claims for COVID-19 testing, treatment and vaccination since the Uninsured Program’s inception, and the Program has proven to be a critical resource for ensuring access to COVID-19 services for uninsured individuals.

© 2022 Foley & Lardner LLPNational Law Review, Volume XII, Number 77
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

Judith Waltz, False Claims Act Attorney, Foley Lardner Law Firm
Partner

Judith A. Waltz is a partner and business lawyer with Foley & Lardner LLP. Her practice focuses on government investigations, false claims act, corporate integrity agreements (CIAs), bankruptcy, and Medicare and Medicaid counseling. Ms. Waltz works with clients in various areas of the health care industry. She is former co-chair of the firm’s Life Sciences Industry Team, and former vice chair of the Health Care Industry Team. Ms. Waltz is also a member of the Government Enforcement, Compliance & White Collar Defense and Bankruptcy & Business Reorganizations...

415-438-6412
Olivia King Health Care Lawyer Foley Lardner Boston
Associate

Olivia King is an associate with Foley & Lardner LLP and a member of the firm’s Health Care Industry Team.

Olivia was selected for the inaugural Mayo-Foley Health Law Fellowship, consisting of summer internships with the Mayo Clinic Legal Department in Rochester, Minnesota (2017), and Foley (2018).While at the Mayo Clinic, Olivia researched and prepared memorandum on state and federal medical prescribing and licensure requirements with analysis of potential implications on telemedicine initiatives and state mental health ombudsman reporting...

617.226.3165
Advertisement
Advertisement
Advertisement